Abstract: Some embodiments of the present application are related to multivesicular liposome (MVL) formulations encapsulating dexamethasone or an ester or an ester salt thereof, for example, dexamethasone sodium phosphate (DSP) that may provide about 3-28 days extended release of dexamethasone. Processes of making and administering dexamethasone encapsulated multivesicular liposome formulations and their uses for treating pain or inflammation are also provided.

Abstract: Some embodiments of the present application are related to multivesicular liposome formulations comprising high concentration of bupivacaine for the purpose of preventing, treating or ameliorating pain, for example, post-surgical pain for an extended period of time. Processes of making and administering bupivacaine encapsulated multivesicular liposome formulations (BUP-MVLs) and their uses as medicaments are also provided.

Abstract: A method comprises receiving a request to predict a type and a quantity of respective ones of a plurality of resources for a computing environment. Using a multiple output classification and regression machine learning model, the type and the quantity of the respective ones of the plurality of resources are predicted in response to the request. The machine learning model is trained with a dataset comprising historical resource data corresponding to respective ones of a plurality of users.

Abstract: A method comprises receiving a request to predict a type and a quantity of respective ones of a plurality of resources for a computing environment. Using a multiple output classification and regression machine learning model, the type and the quantity of the respective ones of the plurality of resources are predicted in response to the request. The machine learning model is trained with a dataset comprising historical resource data corresponding to respective ones of a plurality of users.

Abstract: Enterprise organizations may use observational data to gather information about user experiences with their products and tools. For instance, patients with kidney failure may undergo dialysis treatment in order to remove toxins and excess fluids from their blood. The dialysis treatment may be performed at a hospital or clinic, or in a user's home, and the enterprise organization may use gathered information to gain understanding of user experiences with their dialysis machines and services. A user experience computing system gathers and processes user experience information from across the enterprise organization. Using stored observation data (e.g., surveys, studies etc.) in its smallest common form, the computing system may use this data as building blocks for creating more complex data objects (e.g. journey matrices and/or empathy gardens) using inputs from multiple different sources, and to facilitate presenting this information in an effective and empathetic way to product developers.

Abstract: An eartip includes a first portion that defines a cavity for receiving an earbud and an aperture. The eartip also includes a second portion that overlies the aperture and is formed of an electrically conductive material. An electrically conductive plug has a first end disposed within the aperture and a second end is coupled to the second portion to provide an electrically conductive path between the second portion and the cavity.

Abstract: Some embodiments of the present application are related to multivesicular liposome formulations comprising high concentration of bupivacaine for the purpose of preventing, treating or ameliorating pain, for example, post-surgical pain for an extended period of time. Processes of making and administering bupivacaine encapsulated multivesicular liposome formulations (BUP-MVLs) and their uses as medicaments are also provided.

Abstract: Some embodiments of the present application are related to multivesicular liposome (MVL) formulations encapsulating dexamethasone or an ester or an ester salt thereof, for example, dexamethasone sodium phosphate (DSP) that may provide about 3-28 days extended release of dexamethasone. Processes of making and administering dexamethasone encapsulated multivesicular liposome formulations and their uses for treating pain or inflammation are also provided.

Abstract: A relaxation mask includes: a main body that defines a pair of eye cavities; and a light diffuser. The light diffuser includes a first lens that is disposed within a first one of the eye cavities. A first ledge is disposed along a top edge of the first lens and extends outwardly therefrom. A first light emitting component is supported on the first ledge and is configured to fire downward into the first lens.

Abstract: A relaxation mask includes: a main body that defines a pair of eye cavities; wiring; an earpiece that is coupled to the main body via the wiring; and a spring configured to bias the earpiece towards the main body.

Abstract: A light fixture controller is configured for controlling the color temperature and intensity of a light fixture that includes at least two LED groups. Each LED group includes multiple LEDs configured to produce light at certain color temperatures. The light fixture controller receives a color temperature setting and an intensity setting for the light fixture and generates control signals based on these settings. A first control signal only turns on the first LED group for a first duration of a cycle and a second control signal only turns on the second LED group for a second duration of the cycle. The ratio between the first and second duration is determined based on the color temperature setting. The control signal further includes a dimming control signal for controlling a current flowing through the LED groups based on the intensity setting for the light fixture.

Abstract: A relaxation mask includes: a main body that defines a pair of eye cavities; and a light diffuser. The light diffuser includes a first lens that is disposed within a first one of the eye cavities. A first ledge is disposed along a top edge of the first lens and extends outwardly therefrom. A first light emitting component is supported on the first ledge and is configured to fire downward into the first lens.

Abstract: Some embodiments of the present application are related to multivesicular liposome formulations comprising dexmedetomidine (DXM) for the purpose of minimizing the side effects of immediate release formulation of dexmedetomidine while lengthening the duration of the effect with clinically meaniningful efficacy. Processes of making and administering DXM encapsulated multivesicular liposome formulations (DXM-MVLs) and their uses as medicaments are also provided.

Abstract: Embodiments of the present application relate to commercial manufacturing processes for making bupivacaine multivesicular liposomes (MVLs) using independently operating dual tangential flow filtration modules.

Abstract: Embodiments of the present application relate to compositions of multivesicular liposomes (MVLs) and commercial manufacturing processes for making bupivacaine MVLs.

Abstract: Embodiments of the present application relate to commercial manufacturing processes for making bupivacaine multivesicular liposomes (MVLs) using independently operating dual tangential flow filtration modules.

Abstract: Enterprise organizations may use observational data to gather information about user experiences with their products and tools. For instance, patients with kidney failure may undergo dialysis treatment in order to remove toxins and excess fluids from their blood. The dialysis treatment may be performed at a hospital or clinic, or in a user's home, and the enterprise organization may use gathered information to gain understanding of user experiences with their dialysis machines and services. A user experience computing system gathers and processes user experience information from across the enterprise organization. Using stored observation data (e.g., surveys, studies etc.) in its smallest common form, the computing system may use this data as building blocks for creating more complex data objects (e.g. journey matrices and/or empathy gardens) using inputs from multiple different sources, and to facilitate presenting this information in an effective and empathetic way to product developers.

Abstract: Embodiments of the present application relate to commercial manufacturing processes for making bupivacaine multivesicular liposomes (MVLs) using independently operating dual tangential flow filtration modules.

Abstract: Embodiments of the present application relate to commercial manufacturing processes for making bupivacaine multivesicular liposomes (MVLs) using independently operating dual tangential flow filtration modules.

Abstract: Embodiments of the present application relate to commercial manufacturing processes for making bupivacaine multivesicular liposomes (MVLs) using independently operating dual tangential flow filtration modules.